Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.05 per share
-
Shares outstanding
-
95.5M
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
15.4M
-
Shares change
-
-863K
-
Total reported value, excl. options
-
$194M
-
Value change
-
-$11.5M
-
Put/Call ratio
-
0.86
-
Number of buys
-
30
-
Number of sells
-
-32
-
Price
-
$12.61
Significant Holders of Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) as of Q3 2021
81 filings reported holding CLLS - Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share as of Q3 2021.
Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.4M shares
of 95.5M outstanding shares and own 16.12% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (3.78M shares), Capital International Investors (1.34M shares), PRINCIPAL FINANCIAL GROUP INC (1.24M shares), CREDIT SUISSE AG/ (1.2M shares), BAILLIE GIFFORD & CO (1.08M shares), Capital World Investors (875K shares), CAPITAL INTERNATIONAL INC /CA/ (863K shares), Nikko Asset Management Americas, Inc. (696K shares), Sumitomo Mitsui Trust Holdings, Inc. (696K shares), and Bpifrance SA (426K shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.